Literature DB >> 11793459

Texture analysis of human liver.

Daniel Jirák1, Monika Dezortová, Pavel Taimr, Milan Hájek.   

Abstract

PURPOSE: To classify healthy and diseased livers by texture analysis (TA).
MATERIALS AND METHODS: We studied 43 patients divided into four groups according to their clinical stage and 10 controls on a 1.5-T magnetic resonance (MR) imager, using a T2-weighted breath-hold sequence. For the TA, features of the first and second order were used, and several classification procedures were applied for the classification of patients and controls. The choice of features was performed manually and by use of the Fischer coefficient, average correlation coefficients between features and multidimensional discrimination measure.
RESULTS: All the statistical methods employed were able to differentiate between controls and patients in each group. The classification error varied around 8%.
CONCLUSION: We have shown that texture analysis can be successfully used for separating cirrhotic patients and healthy volunteers. Different sets of TA features can be used for a similar classification of patients. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11793459     DOI: 10.1002/jmri.10042

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  26 in total

1.  Radiomics: a new application from established techniques.

Authors:  Vishwa Parekh; Michael A Jacobs
Journal:  Expert Rev Precis Med Drug Dev       Date:  2016-03-31

2.  Quantitative Assessment of Variation in CT Parameters on Texture Features: Pilot Study Using a Nonanatomic Phantom.

Authors:  K Buch; B Li; M M Qureshi; H Kuno; S W Anderson; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-24       Impact factor: 3.825

3.  Magnetic resonance imaging texture analysis classification of primary breast cancer.

Authors:  S A Waugh; C A Purdie; L B Jordan; S Vinnicombe; R A Lerski; P Martin; A M Thompson
Journal:  Eur Radiol       Date:  2015-06-12       Impact factor: 5.315

Review 4.  Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.

Authors:  Jeanne M Horowitz; Sudhakar K Venkatesh; Richard L Ehman; Kartik Jhaveri; Patrick Kamath; Michael A Ohliger; Anthony E Samir; Alvin C Silva; Bachir Taouli; Michael S Torbenson; Michael L Wells; Benjamin Yeh; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2017-08

Review 5.  Diffusion-weighted imaging and texture analysis: current role for diffuse liver disease.

Authors:  Sofia Gourtsoyianni; Joao Santinha; Celso Matos; Nikolaos Papanikolaou
Journal:  Abdom Radiol (NY)       Date:  2020-10-16

6.  Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations.

Authors:  Jin-Young Choi; Honsoul Kim; Mark Sun; Claude B Sirlin
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

7.  Using Texture Analysis to Determine Human Papillomavirus Status of Oropharyngeal Squamous Cell Carcinomas on CT.

Authors:  K Buch; A Fujita; B Li; Y Kawashima; M M Qureshi; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-02       Impact factor: 3.825

Review 8.  Image texture characterization using the discrete orthonormal S-transform.

Authors:  Sylvia Drabycz; Robert G Stockwell; J Ross Mitchell
Journal:  J Digit Imaging       Date:  2008-08-02       Impact factor: 4.056

9.  Impact of TIEG1 on the structural properties of fast- and slow-twitch skeletal muscle.

Authors:  Malek Kammoun; Sandra Meme; William Meme; Malayannan Subramaniam; John R Hawse; Francis Canon; Sabine F Bensamoun
Journal:  Muscle Nerve       Date:  2016-12-05       Impact factor: 3.217

10.  Non-Hodgkin lymphoma response evaluation with MRI texture classification.

Authors:  Lara C V Harrison; Tiina Luukkaala; Hannu Pertovaara; Tuomas O Saarinen; Tomi T Heinonen; Ritva Järvenpää; Seppo Soimakallio; Pirkko-Liisa I Kellokumpu-Lehtinen; Hannu J Eskola; Prasun Dastidar
Journal:  J Exp Clin Cancer Res       Date:  2009-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.